Gencor Releases Fiscal Year And Fourth Quarter 2013 Results

ORLANDO, Fla., Dec. 13, 2013 (GLOBE NEWSWIRE) -- Gencor Industries, Inc., (Nasdaq:GENC) announced today net revenue for the year ended September 30, 2013 was $48.9 million compared to $63.2 million for the year ended September 30, 2012, a 22.5% decrease. Gross margin as a percentage of net revenue increased to 22.5% for the year ended September 30, 2013 from 19.0% for the year ended September 30, 2012. Operating income for the year ended September 30, 2013 was $2.6 million compared to $0.4 million for the year ended September 30, 2012.

The Company had non-operating, net investment income of $3.8 million for the year ended September 30, 2013 compared to $6.5 million for the year ended September 30, 2012. The effective income tax rate for fiscal 2013 was a benefit of (6.2%) versus expense of 34.7% in fiscal 2012. The tax benefit in fiscal 2013 was primarily due to $2,129,000 of research and development tax credits ("R&D Credits") for fiscal years 2007 through 2013. The Company's net income was $6.7 million ($.71 per basic and diluted share) for the year ended September 30, 2013, compared to net income of $4.5 million ($.47 per basic and diluted share) for the year ended September 30, 2012.

Net revenue for the quarter ended September 30, 2013 was $7.6 million compared to $14.0 million for the quarter ended September 30, 2012, a 45.9% decrease. Traditionally the Company has an operating loss in the fourth quarter due to the seasonality of the business. The loss from operations for the quarter ended September 30, 2013 was $(3) thousand compared to $(1.4) million for the quarter ended September 30, 2012. The Company had non-operating, net investment income of $1.1 million for the quarter ended September 30, 2013 compared to $1.2 million for the quarter ended September 30, 2012. The Company had a tax benefit of $(1.2) million for the quarter ended September 30, 2013 compared to tax expense of $0.1 million for the quarter ended September 30, 2012. The tax benefit was primarily due to $1.0 million of R&D Credits. Net income for the quarter ended September 30, 2013 was $2.2 million ($.24 per basic and diluted share) compared to a net loss of $(0.4) million (a negative $(.04) per basic and diluted share) for the quarter ended September 30, 2012. 

If you liked this article you might like

How My Outperforming Value Portfolio Is Bucking the Trend

Spinning My Small-Cap Value Wheels Out of the Gate

Catch These Names in My 'Double-Net' Value Portfolio for 2017

Insider Trading Alert - CNBKA, GENC And FNGN Traded By Insiders

Insider Trading Alert - GENC, IFF And PCLN Traded By Insiders